Equities researchers at Wedbush boosted their FY2025 EPS estimates for shares of VICI Properties in a report released on Wednesday, February 26th. Wedbush analyst R. Anderson now forecasts that the ...

Equities researchers at Wedbush boosted their Q4 2024 earnings per share estimates for Playtika in a research report issued on Wednesday, February 26th. Wedbush analyst M. Pachter now forecasts that ...

Nvidia executives struck a cautious note on the company’s China business during its quarterly earnings call Wednesday. CEO ...

Wedbush analyst Laura Chico downgraded Praxis Precision (PRAX) to Underperform from Neutral with a price target of $26, down from $57, after ...

Praxis Precision Medicines (PRAX) stock falls amid concerns over success in its late-stage trial for lead asset ulixacaltamide in essential tremor. Read more here.

Super Micro stock plunged more than 25% this week, extending the stock’s long streak of volatility as investors weigh the company’s AI-fueled growth against questionable accounting practices, growing ...

Williams-Sonoma (WSM) is expected to issue a cautious 2025 outlook when it reports fourth-quarter results next month amid softening demand trends for home furnishings goods, Wedbush Securities said in ...

Wedbush analyst David Nierengarten maintained a Buy rating on Spyre Therapeutics (SYRE – Research Report) today and set a price target of ...